ストックスクリーナーアプリを入手
47.44
7.67%
3.38
アフターアワーズ：
47.44
前日終値:
$44.06
開ける：
$43.78
24時間の取引高:
227.80K
Relative Volume:
1.69
時価総額：
$699.87M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+4.65%
1か月 パフォーマンス:
+7.74%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$43.28
$48.47
1週間の範囲:
$42.81
$48.85
52週間の値動き範囲:
$15.00
$53.34
Tectonic Therapeutic Inc Stock (TECX) Company Profile
TECX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
47.44 | 699.87M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-20 | 開始されました | Raymond James | Outperform |
| 2024-08-22 | 開始されました | Wells Fargo | Overweight |
| 2024-06-26 | 開始されました | Piper Sandler | Overweight |
| 2024-06-24 | 開始されました | TD Cowen | Buy |
| 2023-12-18 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-01-05 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-11-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-05-27 | 開始されました | Needham | Buy |
| 2021-03-09 | 開始されました | Barclays | Overweight |
| 2021-03-02 | 開始されました | Stifel | Hold |
| 2020-11-11 | 開始されました | Berenberg | Buy |
| 2020-03-31 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | 開始されました | Mizuho | Buy |
| 2019-04-05 | 開始されました | Janney | Buy |
| 2018-10-10 | 開始されました | Guggenheim | Buy |
| 2018-10-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-09-17 | 開始されました | H.C. Wainwright | Buy |
| 2018-07-16 | 開始されました | Wedbush | Outperform |
| 2018-07-16 | 開始されました | Wells Fargo | Outperform |
すべてを表示
Tectonic Therapeutic Inc (TECX) 最新ニュース
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 7.1%Should You Sell? - MarketBeat
Analysts Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $72.25 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 5.5%Time to Buy? - MarketBeat
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $72.25 - MarketBeat
Fmr LLC Grows Position in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Fmr LLC Has $36.97 Million Holdings in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Verition Fund Management LLC Sells 25,902 Shares of Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Walleye Capital LLC Raises Stock Holdings in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic to Host KOL Event on the Unmet Need in - GlobeNewswire
Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024 - Yahoo Finance
Acuta Capital Partners LLC Invests $415,000 in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Wells Fargo Initiates Coverage of Tectonic Therapeutic (TECX) with Overweight Recommendation - MSN
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference - GlobeNewswire
Tectonic started at outperform by Raymond James, TX45 cited - MSN
Comparing Cellectis (NASDAQ:CLLS) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic started at outperform by Raymond James, TX45 cited (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Raymond James - MarketBeat
Tectonic Therapeutic initiated with an Outperform at Raymond James - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High Following Analyst Upgrade - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $69.00 - Defense World
Tectonic Therapeutic Inc. Faces Challenges with Australian Subsidiary Amid Regulatory and Operational Risks - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High on Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Analyst Upgrade - Defense World
Tectonic Therapeutic Inc. Reports Q3 2024 Results - Yahoo Finance
BML Capital Management LLC Sells 254,295 Shares of Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Insiders of Tectonic Therapeutic, Inc. (NASDAQ:TECX) were rewarded after last week’s 10% gain - Simply Wall St
Tectonic Therapeutic price target raised to $79 from $55 at Wells Fargo - TipRanks
Tectonic Therapeutic Announces Positive Phase 1a Results in - GlobeNewswire
Tectonic's TX45 Shows Strong Phase 1 Results: 42% Renal Flow Boost, 20-Day Half-Life | TECX Stock News - StockTitan
Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.38 - Defense World
Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Price Target at $68.50 - Defense World
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives $23.83 Average PT from Analysts - Defense World
Vitro Diagnostics (OTCMKTS:VODG) and Tectonic Therapeutic (NASDAQ:TECX) Critical Comparison - Defense World
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic Therapeutic (NASDAQ:TECX) Reaches New 12-Month HighStill a Buy? - MarketBeat
Mineralys Therapeutics to Participate in Upcoming Investor Conferences - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month High – Still a Buy? - Defense World
Reviewing Tectonic Therapeutic (NASDAQ:TECX) and Mesoblast (NASDAQ:MESO) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sets New 1-Year HighTime to Buy? - MarketBeat
X4 Pharmaceuticals (NASDAQ:XFOR) vs. Tectonic Therapeutic (NASDAQ:TECX) Critical Analysis - Defense World
Tectonic Therapeutic Independent Director Acquires 7.0% More Stock - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High on Insider Buying Activity - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High Following Insider Buying Activity - MarketBeat
Timothy Springer acquires $10.08 million in Tectonic Therapeutic stock By Investing.com - Investing.com Australia
Tectonic Therapeutic (NASDAQ:TECX) Director Acquires $10,077,000.00 in Stock - MarketBeat
Timothy Springer acquires $10.08 million in Tectonic Therapeutic stock - Investing.com India
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement - The Manila Times
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024 - The Bakersfield Californian
Tectonic Therapeutic Inc (TECX) 財務データ
Tectonic Therapeutic Inc (TECX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):